MedTrace Logo

Pilot Evaluation to Assess the Clinical and Economic Impact of Pfizer's Pain Management Program (painPREMIER) in the Treatment of Low Back Pain, in an Occupational Health Care Setting in Finland

NCT01787565 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 86

Last updated 2016-04-06

No results posted yet for this study

Summary

The aim of this investigation is to determine whether the use of painPREMIER will significantly improve function in patients with low back pain in an occupational health clinical setting. painPREMIER is a tool that assists clinicians in the accurate diagnosis of back pain and associated problems in order to treat them most effectively.

Conditions

Interventions

OTHER

painPREMIER cohort

Low back pain patients prospectively recruited during the study period and managed with painPREMIER.

OTHER

Control cohort

A matched group of low back pain patients not managed with painPREMIER.

Sponsors & Collaborators

  • Terveystalo

    collaborator OTHER

  • Pfizer

    lead INDUSTRY

Principal Investigators

  • Pfizer CT.gov Call Center · Pfizer

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-01-31
Completion
2014-01-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01787565 on ClinicalTrials.gov